Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04543825 · ClinicalTrials.gov registry record
Usefulness of Cardiopulmonary Exercise Testing for Cardiovascular Risk Estimation and Frailty Assessment in Liver Transplant Candidates
A clinical trial of Cardiovascular Diseases+Liver Transplantation, sponsored by Andres Duarte-Rojo.
- Completed
- Registry status
- 54
- Enrollment target
- 2
- Study locations
NCT04543825 is a study of Cardiovascular Diseases+Liver Transplantation that has completed, run by Andres Duarte-Rojo. The registered enrollment target is 54 participants. The trial reports 2 study locations across 2 states.
The verdict
NCT04543825, a study of Cardiovascular Diseases+Liver Transplantation, has completed, sponsored by Andres Duarte-Rojo.
- COMPLETED
- Registry status
- 54 participants
- Enrollment target
- 2
- Study locations
Study Summary
Patients undergoing liver transplantation (LT) have a high risk for cardiovascular disease (CVD). Frailty is a frequent condition among LT candidates. Together, CVD and frailty are major causes of morbidity and mortality before and after LT. Conventional methods to diagnose and predict CVD in LT candidates lack sensitivity and clinically relevant application. However, cardiopulmonary exercise testing (CPET) can directly estimate coronary artery disease, cirrhotic cardiomyopathy, and indirectly assess frailty. Such versatility of CPET has caused it to become the standard of care in many LT centers outside of the United States. In preliminary work (funded internally by the Pittsburgh Liver Research Center) that will be used to fund a more definitive study (RO1), the investigators plan to investigate CVD and frailty in LT candidates, both from existing standard of care (SOC) methods and CPET. The investigators expect results to improve the current capacity to assess and prognosticate CVD and frailty in LT, ultimately changing practice.
Conditions Studied
Interventions
- DEVICE Cardiopulmonary exercise testing
Study Locations (2)
Arizona
- Mayo Clinic Arizona - Phoenix
Pennsylvania
- University of Pittsburgh Medical Center - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2020-09-25 |
| Est. Completion | 2022-05-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04543825
The ClinicalTrials.gov registry entry for NCT04543825 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 54 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Andres Duarte-Rojo, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cardiovascular Diseases+Liver Transplantation appearing as the primary indexed condition, and to 1 intervention - of which Cardiopulmonary exercise testing is the first listed.
NCT04543825 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Arizona, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT04543825 about?
NCT04543825 is a clinical study titled "Usefulness of Cardiopulmonary Exercise Testing for Cardiovascular Risk Estimation and Frailty Assessment in Liver Transplant Candidates". Patients undergoing liver transplantation (LT) have a high risk for cardiovascular disease (CVD). Frailty is a frequent condition among LT candidates. Together, CVD and frailty are major causes of morbidity and mortality before and after LT. Conventional methods to diagnose and predict CVD in LT can...
What is the current status of trial NCT04543825?
This trial is currently completed. The enrollment target is 54 participants. The study started on 2020-09-25. Estimated completion is 2022-05-31.
What conditions does trial NCT04543825 study?
This clinical trial studies the following conditions: Cardiovascular Diseases+Liver Transplantation.
What interventions are being tested in trial NCT04543825?
The interventions under investigation include: Cardiopulmonary exercise testing (DEVICE).
Who is sponsoring clinical trial NCT04543825?
This trial is sponsored by Andres Duarte-Rojo, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04543825 being conducted?
This trial has 2 study locations across Arizona, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.